Varied autopsy findings in five treated patients with Gaucher disease and parkinsonism include the absence of Gaucher cells

Molecular Genetics and Metabolism

Volumn 118, Issue 1, 2016, Pages 55-59

  Monestime, Gianina ^a   Borger, Daniel K ^a   Kim, Jenny ^a   Lopez, Grisel ^a   Allgaeuer, Michael ^b   Jain, Dhanpat ^c   Vortmeyer, Alexander ^c   Wang, Hao Wei ^b   Sidransky, Ellen ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autopsy reports; Enzyme replacement therapy; Gaucher disease; Modifier genes

Indexed keywords

ALGLUCERASE; ANTIHISTAMINIC AGENT; IMIGLUCERASE; VELAGLUCERASE ALFA;

ADULT; AGED; ARTICLE; AUTOPSY; BONE MARROW BIOPSY; CLINICAL ARTICLE; DIFFUSE LEWY BODY DISEASE; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; ENZYME REPLACEMENT; FEMALE; GAUCHER DISEASE; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; MALE; MIDDLE AGED; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; RASH; SPLENECTOMY; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; COMPLICATION; DRUG ADMINISTRATION; PATHOLOGY; PROCEDURES; TREATMENT OUTCOME;

AGED; AUTOPSY; DRUG ADMINISTRATION SCHEDULE; ENZYME REPLACEMENT THERAPY; FEMALE; GAUCHER DISEASE; HUMANS; MALE; MIDDLE AGED; PARKINSONIAN DISORDERS; TREATMENT OUTCOME;

EID: 84961146521     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2016.02.008     Document Type: Article

References (11)

1. Sidransky E. Gaucher disease: insights from a rare Mendelian disorder. Discov. Med. 2012, 14:273-281.
2. Chen M., Wang J. Gaucher disease: review of the literature. Arch. Pathol. Lab. Med. 2008, 132:851-853.
3. Cox T.M., Schofield J.P. Gaucher's disease: clinical features and natural history. Bailliere's Clin. Haematol. 1997, 10:657-689.
4. Charrow J., Scott C.R. Long-term treatment outcomes in Gaucher disease. Am. J. Hematol. 2015, 90(Suppl. 1):S19-S24.
5. Burrow T.A., Sun Y., Prada C.E., Bailey L., Zhang W., Brewer A., Wu S.W., Setchell K.D., Witte D., Cohen M.B., Grabowski G.A. CNS, lung, and lymph node involvement in Gaucher disease type 3 after 11 years of therapy: clinical, histopathologic, and biochemical findings. Mol. Genet. Metab. 2015, 114:233-241.
6. Adachi Y., Kobayashi Y., Ida H., Yasumizu R., Okamura A., Kayatani H., Teranishi N., Inaba M., Sugihara A., Genba H., Eto Y., Ikehara S. An autopsy case of fetal Gaucher disease. Acta Paediatr. Jpn. 1998, 40:374-377. Overseas Edition.
7. Takahashi T., Yoshida Y., Sato W., Yano T., Shoji Y., Sawaishi Y., Sakuma I., Sashi T., Enomoto K., Ida H., Takada G. Enzyme therapy in Gaucher disease type 2: an autopsy case. Tohoku J. Exp. Med. 1998, 186:143-149.
8. Wong K., Sidransky E., Verma A., Mixon T., Sandberg G.D., Wakefield L.K., Morrison A., Lwin A., Colegial C., Allman J.M., Schiffmann R. Neuropathology provides clues to the pathophysiology of Gaucher disease. Mol. Genet. Metab. 2004, 82:192-207.
9. Hulkova H., Ledvinova J., Poupetova H., Kohout A., Malinova V., Elleder M. Autopsy case of Gaucher disease type I in a patient on enzyme replacement therapy. Comments on the dynamics of persistent storage process. J. Inherit. Metab. Dis. 2009, 32:551-559.
10. Koprivica V., Stone D.L., Park J.K., Callahan M., Frisch A., Cohen I.J., Tayebi N., Sidransky E. Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease. Am. J. Hum. Genet. 2000, 66:1777-1786.
11. Elleder M. Glucosylceramide transfer from lysosomes-the missing link in molecular pathology of glucosylceramidase deficiency: a hypothesis based on existing data. J. Inherit. Metab. Dis. 2006, 29:707-715.